ERCC1 and skin squamous cell carcinoma: FTO enhances the chemoradiotherapy resistance of cervical squamous cell carcinoma (CSCC) by positively regulating β-catenin expression via mRNA demethylation and in turn increasing excision repair cross-complementation group 1 (ERCC1) activity85.